MARKET

VYGR

VYGR

Voyager Therapeutics Inc
NASDAQ
4.350
+0.120
+2.84%
Closed 17:51 12/04 EST
OPEN
4.200
PREV CLOSE
4.230
HIGH
4.440
LOW
4.170
VOLUME
491.19K
TURNOVER
0
52 WEEK HIGH
7.44
52 WEEK LOW
2.645
MARKET CAP
241.86M
P/E (TTM)
-2.0049
1D
5D
1M
3M
1Y
5Y
1D
Alzheimer's Clinical Trial Results, Sadly Running True To Form
Seeking Alpha · 1d ago
H.C. Wainwright Sticks to Their Buy Rating for Voyager Therapeutics (VYGR)
TipRanks · 1d ago
Weekly Report: what happened at VYGR last week (1124-1128)?
Weekly Report · 4d ago
J&J Halts Alzheimer's Trial After Drug Fails To Slow Clinical Decline
Benzinga · 11/25 17:22
Weekly Report: what happened at VYGR last week (1117-1121)?
Weekly Report · 11/24 10:01
Weekly Report: what happened at VYGR last week (1110-1114)?
Weekly Report · 11/17 10:01
Benign Growth For Voyager Therapeutics, Inc. (NASDAQ:VYGR) Underpins Stock's 26% Plummet
Simply Wall St · 11/15 12:21
Earnings Update: Voyager Therapeutics, Inc. (NASDAQ:VYGR) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Simply Wall St · 11/14 10:04
More
About VYGR
Voyager Therapeutics, Inc. is a biotechnology company engaged in leveraging the power of human genetics to modify the course of neurological diseases. The Company’s pipeline includes programs for Alzheimer’s disease, Friedreich’s ataxia, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and multiple other diseases of the central nervous system. Many of its programs are derived from its Tropism Redirection of AAV by Cell-type-specific Expression of RNA (TRACER) adeno-associated virus (AAV) capsid discovery platform, which is used to generate capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Its pipeline of programs includes Anti-Tau Antibody (VY7523), Tau Silencing Gene Therapy (VY1706), SOD1 Silencing Gene Therapy Program, Vectorized Anti-Amyloid Antibody Early Research Program, Friedreich’s Ataxia Program: VY-FXN01, GBA1 Gene Replacement Program, HD Program and others.

Webull offers Voyager Therapeutics Inc stock information, including NASDAQ: VYGR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VYGR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VYGR stock methods without spending real money on the virtual paper trading platform.